The killer animatronics of Five Nights at Freddy's are back with a vengeance in the upcoming sequel, which has just dropped a troubling teaser. Released in 2023, the Blumhouse flick was a hit despite ...

Five Nights at Freddy's 2 debuted its first teaser trailer, confirming the appearance of several animatronics that are both ...

The finale of Severance's second season, entitled 'Cold Harbor', delivered some of the series' most bizarre and eerie moments to date. The episode, which featured elements as diverse as goats and ...

Dan is a senior editor at Raw Story based in Colorado, producing and editing breaking political news. Dan previously worked as a news associate at The Associated Press in Philadelphia, and later ...

However, FNAF games are best played in the right pace and order to keep up with the story. So, if you’re a newbie jumping into this haunting animatronic world, keep reading our dedicated guide to know ...

Dementia is a loss of brain function that affects memory, thinking, judgment, behavior, and language. Alzheimer's disease is the most common type of dementia. While there's no cure for dementia, ...

Research connects vision to a later dementia diagnosis. Scientists found visual sensitivity tests could predict dementia up to 12 years before it was diagnosed. Neurologists say more work is ...

A recent study determined the lifetime risk of developing dementia is double that of previous estimates. But there’s good news here too. Alzheimer's disease is a common cause of dementia.

Share on Pinterest Excessive sleepiness as we grow older may be a warning sign of dementia, new research says. Image credit: francesco_de_napoli/Getty Images. At least 55 million people are living ...

The magazine’s Ethicist columnist on the obligations we have to a spouse with a degenerative illness. By Kwame Anthony Appiah My husband of 52 years was diagnosed with Alzheimer’s disease 10 ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study.

An experimental anti-amyloid drug has shown potential in delaying Alzheimer's dementia in individuals with genetic mutations predisposing them to early-onset Alzheimer's.